Injecting a virus-based vector expressing XCL1 and soluble Flt3L intratumorally improved tumor control in MC38- and B16-bearing mice through the accumulation of cross-presenting Batf3 DCs in the tumor draining lymph node [50]. The gene discussed is XCL1; the disease is neoplasm.